GeneDx Holdings Corp. Contract with Customer, Asset, after Allowance for Credit Loss
GeneDx Holdings Corp. (WGS) had Contract with Customer, Asset, after Allowance for Credit Loss of $4.26 million as of 2022-09-30, per its 10-Q filed 2022-11-14.
Discontinued › Balance Sheet › Assets
us-gaap:ContractWithCustomerAssetNet · last filed 2022-11-14
- 2022-09-30: Contract with Customer, Asset, after Allowance for Credit Loss $4.26M.
- 2022-06-30: Contract with Customer, Asset, after Allowance for Credit Loss $4.36M.
- 2022-03-31: Contract with Customer, Asset, after Allowance for Credit Loss $3.75M.
- 2021-12-31: Contract with Customer, Asset, after Allowance for Credit Loss $3.30M.
| Period end | Contract with Customer, Asset, after Allowance for Credit Loss |
|---|---|
| 2022-09-30 | $4.26M 10-Q · filed 2022-11-14 |
| 2022-06-30 | $4.36M 10-Q · filed 2022-08-15 |
| 2022-03-31 | $3.75M 10-Q · filed 2022-05-12 |
| 2021-12-31 | $3.30M 10-Q · filed 2022-11-14 |
| 2021-09-30 | $2.96M 10-Q · filed 2021-11-15 |
| 2020-12-31 | $2.03M 10-K · filed 2022-03-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Privia Health Group, Inc. (PRVA) | United States | $2.477B | 115.52 |
| Pennant Group, Inc. (PNTG) | United States | $1.386B | 39.84 |
| U S PHYSICAL THERAPY INC /NV (USPH) | United States | $1.251B | 32.48 |
| Omada Health, Inc. (OMDA) | United States | $1.207B | 309.08 |
| InnovAge Holding Corp. (INNV) | United States | $1.206B | -635.60 |
| LifeStance Health Group, Inc. (LFST) | United States | $4.510B | 80.86 |
| Strata Critical Medical, Inc. (SRTA) | United States | $0.467B | 11.33 |
| DocGo Inc. (DCGO) | United States | $0.034B | -0.25 |
| VSEE HEALTH, INC. (VSEE) | United States | $0.003B | |
| Agape ATP Corp (ATPC) | $0.002B |